Solubilizing excipients in oral and injectable formulations

被引:1087
作者
Strickley, RG [1 ]
机构
[1] Gilead Sci Inc, Formulat & Proc Dev, Foster City, CA 94404 USA
关键词
excipients; oral formulations; parenteral formulations; solubilization;
D O I
10.1023/B:PHAM.0000016235.32639.23
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
A review of commercially available oral and injectable solution formulations reveals that the solubilizing excipients include water-soluble organic solvents ( polyethylene glycol 300, polyethylene glycol 400, ethanol, propylene glycol, glycerin, N-methyl-2-pyrrolidone, dimethylacetamide, and dimethylsulfoxide), non-ionic surfactants (Cremophor EL, Cremophor RH 40, Cremophor RH 60, d-alpha-tocopherol polyethylene glycol 1000 succinate, polysorbate 20, polysorbate 80, Solutol HS 15, sorbitan monooleate, poloxamer 407, Labrafil M-1944CS, Labrafil M-2125CS, Labrasol, Gellucire 44/14, Softigen 767, and mono- and di-fatty acid esters of PEG 300, 400, or 1750), water-insoluble lipids (castor oil, corn oil, cottonseed oil, olive oil, peanut oil, peppermint oil, safflower oil, sesame oil, soybean oil, hydrogenated vegetable oils, hydrogenated soybean oil, and medium-chain triglycerides of coconut oil and palm seed oil), organic liquids/semi-solids (beeswax, d-alpha-tocopherol, oleic acid, medium- chain mono- and diglycerides), various cyclodextrins (alpha-cyclodextrin, beta-cyclodextrin, hydroxypropyl-beta-cyclodextrin, and sulfobutylether-beta-cyclodextrin), and phospholipids ( hydrogenated soy phosphatidylcholine, distearoylphosphatidylglycerol, L-alpha-dimyristoylphosphatidylcholine, L-alpha-dimyristoylphosphatidylglycerol). The chemical techniques to solubilize water-insoluble drugs for oral and injection administration include pH adjustment, cosolvents, complexation, microemulsions, self-emulsifying drug delivery systems, micelles, liposomes, and emulsions.
引用
收藏
页码:201 / 230
页数:30
相关论文
共 83 条
[1]   Excipient-drug interactions in parenteral formulations [J].
Akers, MJ .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2002, 91 (11) :2283-2300
[2]   Active apical secretory efflux of the HIV protease inhibitors saquinavir and ritonavir in Caco-2 cell monolayers [J].
Alsenz, J ;
Steffen, H ;
Alex, R .
PHARMACEUTICAL RESEARCH, 1998, 15 (03) :423-428
[3]  
[Anonymous], 1998, INTEGRATION PHARM DI
[4]  
[Anonymous], ENCY PHARM TECHNOLOG
[5]  
[Anonymous], 2001, Merck Index
[6]  
Apte S. P., 2003, Pharm. Technol, V27, P46
[7]  
BRAZEAU GA, 1989, J PARENT SCI TECHN, V43, P144
[8]   USE OF AN INVITRO MODEL FOR THE ASSESSMENT OF MUSCLE DAMAGE FROM INTRAMUSCULAR INJECTIONS - INVITRO-INVIVO CORRELATION AND PREDICTABILITY WITH MIXED-SOLVENT SYSTEMS [J].
BRAZEAU, GA ;
FUNG, HL .
PHARMACEUTICAL RESEARCH, 1989, 6 (09) :766-771
[9]   EFFECT OF ORGANIC COSOLVENT-INDUCED SKELETAL-MUSCLE DAMAGE ON THE BIOAVAILABILITY OF INTRAMUSCULAR [C-14] DIAZEPAM [J].
BRAZEAU, GA ;
FUNG, HL .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1990, 79 (09) :773-777
[10]   Current perspectives on pain upon injection of drugs [J].
Brazeau, GA ;
Cooper, B ;
Svetic, KA ;
Smith, CL ;
Gupta, P .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1998, 87 (06) :667-677